Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Liver ; 21(3): 183-91, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11422781

ABSTRACT

BACKGROUND/AIMS: Idoxifene is a tissue-specific selective estrogen receptor modulator. Estradiol is a potent endogenous antioxidant, and nuclear factor kappaB (NF-kappaB) is a key transcription factor that induces multiple genes in response to inflammation or oxidative stress. The aim of this study was to explore the inhibitory effects of idoxifene and estradiol on NF-kappaB activation in hepatocytes in a state of oxidative stress. METHODS: Lipid peroxidation was induced in cultured rat hepatocytes by incubation with ferric nitrilotriacetate solution. NF-kappaB activity was evaluated by electrophoretic mobility shift assay. RESULTS: The oxidative stress-induced activation of NF-kappaB and degradation of IkappaB-alpha were maximal at 3-5 h, with an increase in lactate dehydrogenase (LDH) and malondialdehyde (MDA) secretion into the culture medium. Treatment with idoxifene and estradiol inhibited IkappaB-alpha degradation and NF-kappaB activation through the attenuation of hepatocyte oxidative bursts and decreased extracellular levels of LDH and MDA. In addition, idoxifene and estradiol inhibited lipid peroxidation in rat liver mitochondria. A potent NF-kappaB inhibitor, pyrrolidine dithiocarbamate, prevented NF-kappaB activation by inhibition of IkappaB-alpha degradation and decreased LDH and MDA levels, suggesting that NF-kappaB might be a regulator in a genetic response to increase oxidative stress-induced hepatic injury. CONCLUSIONS: These findings suggest that idoxifene and estradiol function as antioxidants and protect hepatocytes from inflammatory cell injury.


Subject(s)
Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Hepatocytes/drug effects , NF-kappa B/biosynthesis , Oxidative Stress , Tamoxifen/pharmacology , Animals , Antioxidants/pharmacology , Blotting, Western , Cells, Cultured , Culture Media/chemistry , Dose-Response Relationship, Drug , Hepatocytes/metabolism , L-Lactate Dehydrogenase/antagonists & inhibitors , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Microscopy, Confocal , Mitochondria, Liver/drug effects , Mitochondria, Liver/enzymology , NF-kappa B/analysis , NF-kappa B/antagonists & inhibitors , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Tamoxifen/analogs & derivatives , Thiocarbamates/pharmacology , Time Factors
2.
Intern Med ; 40(2): 100-4, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11300139

ABSTRACT

We report an 18-year-old male patient who developed chronic hepatitis C after blood transfusion and had testicular dysfunction after irradiation for a testicular relapse of childhood acute lymphocytic leukemia after cessation of maintenance therapy, and the initiation of testosterone replacement therapy at puberty. Concomitant administration of estradiol resulted in a reduction in serum alanine aminotransferase and ferritin levels and hepatic iron concentration and staining after 2 years of estrogen therapy, although interferon therapy was withdrawn because of adverse effects. This observation suggests that endogenous estradiol may play a beneficial role in male patients with chronic hepatitis C.


Subject(s)
Estradiol/analogs & derivatives , Estradiol/therapeutic use , Estrogen Replacement Therapy , Hepatitis C, Chronic/drug therapy , Hypogonadism/etiology , Radiation Injuries/etiology , Radiotherapy/adverse effects , Testicular Diseases/etiology , Testosterone/analogs & derivatives , Adolescent , Alanine Transaminase/blood , Antiviral Agents/therapeutic use , Biopsy , Collagen/analysis , Combined Modality Therapy , Estradiol/deficiency , Estradiol/physiology , Ferritins/analysis , Follicle Stimulating Hormone/blood , Hepatitis C, Chronic/blood , Hormone Replacement Therapy , Humans , Hypogonadism/drug therapy , Hypogonadism/metabolism , Interferon alpha-2 , Interferon-alpha/therapeutic use , Iron/analysis , Leukemic Infiltration/radiotherapy , Liver/chemistry , Liver/pathology , Luteinizing Hormone/blood , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy , Recombinant Proteins , Testicular Diseases/drug therapy , Testicular Diseases/metabolism , Testis/pathology , Testis/radiation effects , Testosterone/deficiency , Testosterone/therapeutic use , Viral Load
3.
J Gastroenterol Hepatol ; 16(2): 196-201, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11207901

ABSTRACT

BACKGROUND: It has been reported that chronic infection with hepatitis C virus is associated with excess iron deposits in the liver of subjects who are neither alcoholics nor recipients of blood transfusions. However, little is known about the relationship between hepatic iron concentration (HIC) and the serum levels of hepatic fibrogenesis markers, which were caused by interferon therapy for chronic hepatitis C. Therefore, changes in the serum amino-terminal propeptide of type III procollagen (P-III-P) and the 7S domain of type IV collagen (7S-IV) in 16 patients treated with alpha-interferon (IFN-alpha) were studied, and their HIC and histological assessment evaluated. Hepatic iron concentrations were measured by using liver biopsy specimens obtained before and 6 months after the cessation of treatment. METHODS AND RESULTS: Eight subjects (50%) who had normal alanine transaminase levels at 6 months after therapy showed significantly lowered HIC, and attenuated hepatic iron staining with decreased serum levels of P-III-P and 7S-IV compared to the remaining subjects. The HIC was significantly correlated with the serum levels of P-III-P and 7S-IV in all subjects. CONCLUSIONS: These findings suggest that IFN-alpha treatment may decrease stimuli for fibrogenesis, at least in part, by reducing the hepatic iron deposition in patients with chronic hepatitis C.


Subject(s)
Collagen/blood , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Iron/analysis , Liver/chemistry , Procollagen/blood , Adult , Female , Humans , Hyaluronic Acid/blood , Male , Middle Aged , Protein Structure, Tertiary
4.
J Med Invest ; 47(3-4): 145-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11019494

ABSTRACT

We encountered a patient whose blood was sucked by Haemaphysalis longicornis in the suburb of a business city in Tokushima prefecture in Japan. The tick, which had been attached to the lower limb of the patient for one week, measured 10 mm in length. There were no notable objective or subjective findings after the complete extirpation of the tick. The area had not been known in recent history to be a habitat of ticks, and, thus, this case is of importance in terms of predicting future trends of tick-borne diseases in Japan.


Subject(s)
Bites and Stings , Tick-Borne Diseases , Ticks , Aged , Animals , Female , Humans , Japan , Tick-Borne Diseases/prevention & control , Tick-Borne Diseases/transmission
5.
Biochem Mol Biol Int ; 46(5): 1055-61, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9861459

ABSTRACT

To simply and directly evaluate DNA fragmentation during apoptosis induced in mouse cultured hepatocytes by an anti-Fas antibody, we examined the fluorescence intensity in cell nuclei stained with ethidium bromide and 4'-6-diamidino-2-phenylindole by optiphoto fluorescence microscopy. The intensity of the former staining for the nuclear DNA of apoptotic cells was clearly decreased compared to that of non-apoptotic cells, whereas no difference in the fluorescence intensity for the latter stain between the apoptotic and non-apoptotic groups was observed. Thus, the use of optiphoto fluorescence microscopy, in conjunction with both stains, constitutes a useful tool for the evaluation of apoptotic DNA fragmentation.


Subject(s)
Apoptosis , DNA Fragmentation , DNA/metabolism , Ethidium/metabolism , Fluorescent Dyes/metabolism , Indoles/metabolism , Animals , Antibodies/pharmacology , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cells, Cultured , DNA Fragmentation/drug effects , Dactinomycin/pharmacology , Intercalating Agents/metabolism , Liver/cytology , Liver/drug effects , Male , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Staining and Labeling , fas Receptor/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...